Buruli's ulcer: An emerging disease;Úlcera de Buruli: Una enfermedad emergente

Revista Clinica Espanola

Volumn 204, Issue 8, 2004, Pages 422-424

  Garcia Agudo L ^a   Garcia Martos P ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; ISONIAZID; MINOCYCLINE; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

BURULI ULCER; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HUMAN; MYCOBACTERIUM ULCERANS; NOTE; PREVALENCE; ATYPICAL MYCOBACTERIOSIS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; REVIEW; SURGERY; ULCER;

HUMANS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM ULCERANS; SURGICAL PROCEDURES, OPERATIVE; ULCER;

EID: 4444290683     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13064318     Document Type: Note

References (20)

1. Clancey JK. Mycobacterial skin ulcers in Uganda: description of a new mycobacterium. J Pathol Bacteriol 1964;88:175-87.
2. McCallum P, Tolhurst JC, Buckle G, Sissons HA. A new mycobacterial infection in man: clinical aspects. J Pathol Bacteriol 1948;60:93-122.
3. Asiedu K, Scherpbier R, Raviglione M. Buruli ulcer, Mycobacterium ulcerans infection. Geneva: World Health Organization, 2000.
4. Marsollier L, Robert R, Aubry J, Saint-Andre JP, Konakou H, Legras P, et al. Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbio 2002;68:4623-8.
5. Meyers WM, Shelly WM, Connor DH, Meyers EK. Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg 1974;23:919-23.
6. Ameh FA, Dogo PM, Ahmed AJ, Maitama HY, Esangbedo AE, Nmadu PT. Mycobacterium ulcerans skin infection in patient with HIV infection: is this incidental? Trop Doct 1997;27:59.
7. Stienstra Y, van der Graaf WT, Meerman GJ, The TH, de Leij LF, van der Werf TS. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health 2001;6:554-62.
8. Ouattara D, Aka GK, Meningaud JP, Sica A, Kaba L, Gadegbeku S. Les localisations faciales de l'ulcère de Buruli. Rev Stomatol Chir Maxillofac 2003;104:231-4.
9. Snyder DS, Small PL. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans. Microb Pathog 2003; 34:91-101.
10. Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH. Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg 1993;87:644-5.
11. Pszolla N, Sarkar MR, Strecker W, Kern P, Kinzl L, Meyers WM, et al. Buruli ulcer: a systemic disease. Clin Infect Dis 2003;37:78-82.
12. Van der Werf TS, van der Graaf WTA, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 1999;354:1013-8.
13. Guarner J, Bartlett J, Whitney EAS, Raghunathan PL, Stienstra Y, Asamoa K, et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 2003;9:651-6.
14. Chemlal K, Huys G, Fonteyne PA, Vincent V, Lopez AG, Rigouts L, et al. Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum. J Clin Microbiol 2001;39:3272-8.
15. Espey DK, Djomand G, Diomande I, Dosso M, Saki MZ, Kanga JM, et al. A pilot study of treatment of Buruli ulcer with rifampin and dapsone. Int J Infect Dis 2002;6:60-5.
16. Goutzamanis J, Gilbert G. Mycobacterium ulcerans infection in Australian children: report of 8 cases and review. Clin Infect Dis 1995;21: 1186-92.
17. Josse R, Guedenon A, Daric H. Les infections cutanees à Mycobacterium ulcerans: ulceres de Buruli. Med Trop 1995;55:363-73.
18. Kreig RE, Wolcott JH, Meyers WM. Mycobacterium ulcerans infection: treatment with rifampicin, hyperbaric oxygen and heat. Aviat Space Environ Med 1979;50:888-92.
19. Teelken MA, Stienstra Y, Ellen DE, Quarshie E, Klutse E, van der Graaf WT, et al. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop 2003;88:51-6.
20. Portaels F, Aguiar J, Debacker M, Steunou C, Zinsou C, Guedenon A, et al. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 2002;9:1389-91.